Anti-™9SF2 monoclonal antibody

Pre-made anti-™9SF2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to ™9SF2/™9SF2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1928-Ab-1/ GM-Tg-hg-IP1928-Ab-2Anti-Human ™9SF2 monoclonal antibodyHuman
GM-Tg-rg-IP1928-Ab-1/ GM-Tg-rg-IP1928-Ab-2Anti-Rat ™9SF2 monoclonal antibodyRat
GM-Tg-mg-IP1928-Ab-1/ GM-Tg-mg-IP1928-Ab-2Anti-Mouse ™9SF2 monoclonal antibodyMouse
GM-Tg-cynog-IP1928-Ab-1/ GM-Tg-cynog-IP1928-Ab-2Anti-Cynomolgus/ Rhesus macaque ™9SF2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1928-Ab-1/ GM-Tg-felg-IP1928-Ab-2Anti-Feline ™9SF2 monoclonal antibodyFeline
GM-Tg-cang-IP1928-Ab-1/ GM-Tg-cang-IP1928-Ab-2Anti-Canine ™9SF2 monoclonal antibodyCanine
GM-Tg-bovg-IP1928-Ab-1/ GM-Tg-bovg-IP1928-Ab-2Anti-Bovine ™9SF2 monoclonal antibodyBovine
GM-Tg-equg-IP1928-Ab-1/ GM-Tg-equg-IP1928-Ab-2Anti-Equine ™9SF2 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1928-Ab-1/ GM-Tg-hg-IP1928-Ab-2; GM-Tg-rg-IP1928-Ab-1/ GM-Tg-rg-IP1928-Ab-2;
GM-Tg-mg-IP1928-Ab-1/ GM-Tg-mg-IP1928-Ab-2; GM-Tg-cynog-IP1928-Ab-1/ GM-Tg-cynog-IP1928-Ab-2;
GM-Tg-felg-IP1928-Ab-1/ GM-Tg-felg-IP1928-Ab-2; GM-Tg-cang-IP1928-Ab-1/ GM-Tg-cang-IP1928-Ab-2;
GM-Tg-bovg-IP1928-Ab-1/ GM-Tg-bovg-IP1928-Ab-2; GM-Tg-equg-IP1928-Ab-1/ GM-Tg-equg-IP1928-Ab-2
Products NameAnti-™9SF2 monoclonal antibody
Formatmab
Target Name™9SF2
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-™9SF2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1928-Ag-1Recombinant multi-species ™9S2/ ™9SF2/ P76 protein


    Target information

    Target IDGM-IP1928
    Target Name™9SF2
    Gene ID9375,68059,306197,699087,476972,101101536,514455,100061300
    Gene Symbol and Synonyms1500001N15Rik,D14Ertd64e,Lnc-PCIR,P76,™9SF2
    Uniprot AccessionQ99805,Q66HG5
    Uniprot Entry Name™9S2_HUMAN,™9S2_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000125304
    Target ClassificationN/A

    The target: ™9SF2, gene name: ™9SF2, also named as P76. This gene encodes a member of the transmembrane 9 superfamily. The encoded 76 kDa protein localizes to early endosomes in human cells. The encoded protein possesses a conserved and highly hydrophobic C-terminal domain which contains nine transmembrane domains. The protein may play a role in small molecule transport or act as an ion channel. A pseudogene associated with this gene is located on the X chromosome. [provided by RefSeq, Oct 2012].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.